Clinical trials
Trials in Bosnia and Herzegovina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
323 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 10 |
| 2007 | 12 |
| 2008 | 12 |
| 2009 | 18 |
| 2010 | 9 |
| 2011 | 16 |
| 2012 | 6 |
| 2013 | 11 |
| 2014 | 13 |
| 2015 | 15 |
| 2016 | 15 |
| 2017 | 18 |
| 2018 | 27 |
| 2019 | 16 |
| 2020 | 21 |
| 2021 | 19 |
| 2022 | 13 |
| 2023 | 18 |
| 2024 | 19 |
| 2025 | 13 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 200 |
| Terminated | 45 |
| Active, not recruiting | 32 |
| Recruiting | 24 |
| Unknown status | 16 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
| Withdrawn | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 39 |
| Pfizer | 20 |
| AbbVie | 18 |
| University of Mostar | 10 |
| Bayer | 9 |
| Sanofi | 7 |
| Cantonal Hospital Zenica | 6 |
| Celgene | 6 |
| Novo Nordisk A/S | 6 |
| University of Banja Luka | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 22 |
| Crohn Disease | 20 |
| Arthritis, Rheumatoid | 19 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Colitis, Ulcerative | 15 |
| Multiple Sclerosis | 13 |
| Multiple Sclerosis, Relapsing-Remitting | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Colorectal Neoplasms | 6 |
| Epilepsy | 6 |
Trials
Showing 51 to 75 of 323. Each trial links to its page on Pharma Observatory.
223 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.